Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation - Graham, D J; Reichman, M E; Wernecke, M (JAMA Intern Med, 2016)
, et al.